Paul Gissen

Paul Gissen

University College London

H-index: 60

Europe-United Kingdom

About Paul Gissen

Paul Gissen, With an exceptional h-index of 60 and a recent h-index of 48 (since 2020), a distinguished researcher at University College London, specializes in the field of Intracellular trafficking, Inherited Metabolic Disorders.

His recent articles reflect a diverse array of research interests and contributions to the field:

mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria

Cerliponase alfa for the treatment of CLN2 disease in a patient cohort including children under 3 years of age

Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem Cells

RGX-381: Interim results from the first-in-human clinical trial of an investigational gene therapy for the treatment of ocular manifestations of CLN2 Batten disease

Liver‐directed gene therapy for inherited metabolic diseases

Trial of N-Acetyl-l-Leucine in Niemann–Pick Disease Type C

Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study

Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C

Paul Gissen Information

University

Position

UCL Institute of Child Health and Group leader MRC Laboratory of Molecular Cell Biology University

Citations(all)

12856

Citations(since 2020)

7770

Cited By

8264

hIndex(all)

60

hIndex(since 2020)

48

i10Index(all)

133

i10Index(since 2020)

113

Email

University Profile Page

University College London

Google Scholar

View Google Scholar Profile

Paul Gissen Skills & Research Interests

Intracellular trafficking

Inherited Metabolic Disorders

Top articles of Paul Gissen

Title

Journal

Author(s)

Publication Date

mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria

Science translational medicine

Sonam Gurung

Oskar Vilhelmsson Timmermand

Dany Perocheau

Ana Luisa Gil-Martinez

Magdalena Minnion

...

2024/1/10

Cerliponase alfa for the treatment of CLN2 disease in a patient cohort including children under 3 years of age

Molecular Genetics and Metabolism

Angela Schulz

Emily C de los Reyes

Nicola Specchio

Paul Gissen

Peter Slasor

...

2024/2/1

Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem Cells

bioRxiv

Carola M Morell

Samantha Grace Tilson

Rute A Tomaz

Arash Shahsavari

Andi Munteanu

...

2024

RGX-381: Interim results from the first-in-human clinical trial of an investigational gene therapy for the treatment of ocular manifestations of CLN2 Batten disease

Molecular Genetics and Metabolism

Christina Ohnsman

Alexander M Bailey

Wei Huang

Nicholas Buss

Kwi Hye Kim

...

2024/2/1

Liver‐directed gene therapy for inherited metabolic diseases

Julien Baruteau

Nicola Brunetti‐Pierri

Paul Gissen

2024/1

Trial of N-Acetyl-l-Leucine in Niemann–Pick Disease Type C

New England Journal of Medicine

Tatiana Bremova-Ertl

Uma Ramaswami

Marion Brands

Tomas Foltan

Matthias Gautschi

...

2024/2/1

Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study

The Lancet Neurology

Angela Schulz

Nicola Specchio

Emily de Los Reyes

Paul Gissen

Miriam Nickel

...

2024/1/1

Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C

Molecular Genetics and Metabolism

Taylor Fields

Tatiana Bremova-Ertl

Uma Ramaswami

Marion Brands

Matthias Gautschi

...

2024/2/1

Generation of induced pluripotent stem cells (UCLi024-A) from a patient with argininosuccinate lyase deficiency carrying a homozygous c. 437G> A (p. Arg146Gln) mutation

Stem Cell Research

Claire Duff

Madeha Islam

Onelia Gagliano

Hema Pramod

Hassan Rashidi

...

2024/4/1

Fetal gene therapy

Simon N Waddington

William H Peranteau

Ahad A Rahim

Ashley K Boyle

Manju A Kurian

...

2024/1

Characterization of two human induced pluripotent stem cell lines derived from Batten disease patient fibroblasts harbouring CLN5 mutations

Stem Cell Research

Marisa Ofrim

Daniel Little

Mina Nazari

Christopher J Minnis

Michael J Devine

...

2024/2/1

Treatment for lysine degradation-associated disorders

2024/2/8

Targeting the liver to treat the eye

EMBO Molecular Medicine

Berna Seker Yilmaz

Paul Gissen

2023/4/11

Genetic therapy approaches for ornithine transcarbamylase deficiency

Berna Seker Yilmaz

Paul Gissen

2023/8/8

Cardiac glycosides restore autophagy flux in an iPSC-derived neuronal model of WDR45 deficiency

bioRxiv

Apostolos Papandreou

Nivedita Singh

Lorita Gianfrancesco

Dimitri Budinger

Katy Barwick

...

2023/9/13

First in man study of intravitreal tripeptidyl peptidase 1 for CLN2 retinopathy

Eye

James Wawrzynski

Ana Rodriguez Martinez

Dorothy Ann Thompson

Dipak Ram

Richard Bowman

...

2023/12/4

Atidarsagene autotemcel for metachromatic leukodystrophy

Martina Messina

Paul Gissen

2023/2/1

New perspectives in dried blood spot biomarkers for lysosomal storage diseases

International Journal of Molecular Sciences

Justyna Spiewak

Ivan Doykov

Apostolos Papandreou

Jenny Hällqvist

Philippa Mills

...

2023/6/15

Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic …

Human Gene Therapy

Sharon C Cunningham

Eva B van Dijk

Erhua Zhu

Maya Sugden

Mawj Mandwie

...

2023/9/1

The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria

Journal of Inherited Metabolic Disease

Sonam Gurung

Saketh Karamched

Dany Perocheau

Kiran K Seunarine

Tom Baldwin

...

2023/12/4

See List of Professors in Paul Gissen University(University College London)

Co-Authors

H-index: 150
Eamonn Maher

Eamonn Maher

University of Cambridge

H-index: 59
Neil V Morgan

Neil V Morgan

University of Birmingham

H-index: 56
Simon N Waddington

Simon N Waddington

University College London

academic-engine